Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.
about
Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAPPhotodynamic therapy: a new antimicrobial approach to infectious disease?Drug Carrier for Photodynamic Cancer TherapyIs reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenograftsRole of pegaptanib sodium in the treatment of neovascular age-related macular degenerationMicrobial efflux pump inhibition: tactics and strategies.Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps.Efflux pump inhibitor potentiates antimicrobial photodynamic inactivation of Enterococcus faecalis biofilm.Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis)Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacyHistopathological findings in postmortem eyes after photodynamic therapy for choroidal neovascularisation in age-related macular degeneration: report of two cases.YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage.Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation.Ophthalmic light sensitive nanocarrier systems.Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.
P2860
Q24298571-9BBD0CC4-50F7-4FD4-9B7D-4A8201E27462Q24626076-F1C63E61-D26D-4AC6-84A3-5D6F320E2541Q26782780-69FB9F14-B87C-4BDA-B61C-B7872471FC76Q30438969-72E62AE6-0DC2-4EB2-A3A4-E1FFA9FDBA0CQ30611957-AB7840EA-469C-4683-8D9A-A18825640F65Q33492369-C76ED912-2276-499E-8770-721A99E73F40Q34176211-354E6B66-540A-41FE-8ADA-6B3243C563B0Q34301578-6D813316-EE9D-4798-9140-BA6C29159EC1Q34349227-5D8AEE78-DC74-4868-9C73-D7C6FF414412Q35016867-C4F97C09-B48B-419D-B603-FF919780A7BAQ35679856-174E97AF-D240-4530-9821-B538FDA15779Q36172252-83931F7D-CF1E-403F-8881-15DD9DD54A33Q36414976-562E4457-060D-4C60-B57B-85724F7ED44CQ36870800-50D7006F-DEA1-410E-9753-84BCB91768DFQ37085078-16E8514C-30E9-41A2-A2FD-FA985CFE3189Q37389925-C5A08BFA-B6B5-4252-9E6D-4B9A99178A99
P2860
Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Photodynamic therapy with vert ...... halmology and visual sciences.
@ast
Photodynamic therapy with vert ...... halmology and visual sciences.
@en
type
label
Photodynamic therapy with vert ...... halmology and visual sciences.
@ast
Photodynamic therapy with vert ...... halmology and visual sciences.
@en
prefLabel
Photodynamic therapy with vert ...... halmology and visual sciences.
@ast
Photodynamic therapy with vert ...... halmology and visual sciences.
@en
P1476
Photodynamic therapy with vert ...... thalmology and visual sciences
@en
P2093
N M Bressler
S B Bressler
P304
P407
P577
2000-03-01T00:00:00Z